CD8+ T cells are essential for adaptive immunity against infection and tumors. Their ability to proliferate after stimulation is crucial to their functionality. Dendritic cells (DCs) are professional antigen-presenting cells that induce their proliferation. Here, we show that thapsigargin-induced LAD2 mast cell (MC) line-released products can impair the ability of monocyte-derived DCs to induce CD8+ T-cell proliferation and the generation of Th1 cytokine-producing T cells. We found that culture medium conditioned with LAD2 MCs previously stimulated with thapsigargin (thapsLAD2) induces maturation of DCs as determined by the maturation markers CD80, CD83, CD86, and HLA-DR. However, thapsLAD2-matured DCs produced no detectable TNFα or IL-12 during the maturation. In addition, although their surface expression of PD-L1 was comparable with the immature or TLR7/8-agonist (R848)-matured DCs, their TIM-3 expression was significantly higher than in immature DCs and even much higher than in R848-matured DCs. In addition, contrary to R848-matured DCs, the thapsLAD2-matured DCs only tended to induce enhanced proliferation of CD4+ T cells than immature DCs. For CD8+ T cells, this tendency was not even detected because thapsLAD2-matured and immature DCs comparably induced their proliferation, which contrasted with the significantly enhanced proliferation induced by R848-matured DCs. Furthermore, these differences were comparably recapitulated in the ability of the tested DCs to induce IFNγ- and IFNγ/TNFα-producing T cells. These findings show a novel mechanism of MC-mediated regulation of adaptive immune responses.

Department of Immunology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Laboratory of Immunotherapy Institute of Microbiology of the Czech Academy of Sciences Prague Czech Republic

See more in PubMed

Dahlin J. S., Hallgren J. Mast cell progenitors: origin, development and migration to tissues. Molecular Immunology . 2015;63(1):9–17. doi: 10.1016/j.molimm.2014.01.018. PubMed DOI

Banafea G. H., Bakhashab S., Alshaibi H. F., Pushparaj P. N., Rasool M. The role of human mast cells in allergy and asthma. Bioengineered . 2022;13(3):7049–7064. doi: 10.1080/21655979.2022.2044278. PubMed DOI PMC

Numata T., Harada K., Nakae S. Roles of mast cells in cutaneous diseases. Frontiers in Immunology . 2022;13 doi: 10.3389/fimmu.2022.923495.923495 PubMed DOI PMC

Komi D. E. A., Redegeld F. A. Role of mast cells in shaping the tumor microenvironment. Clinical Reviews in Allergy & Immunology . 2020;58(3):313–325. doi: 10.1007/s12016-019-08753-w. PubMed DOI PMC

Sulsenti R., Jachetti E. Frenemies in the microenvironment: harnessing mast cells for cancer immunotherapy. Pharmaceutics . 2023;15(6) doi: 10.3390/pharmaceutics15061692.1692 PubMed DOI PMC

Varricchi G., Rossi F. W., Galdiero M. R., et al. Physiological roles of mast cells: collegium internationale allergologicum update 2019. International Archives of Allergy and Immunology . 2019;179(4):247–261. doi: 10.1159/000500088. PubMed DOI

Carroll-Portillo A., Cannon J. L., te Riet J., et al. Mast cells and dendritic cells form synapses that facilitate antigen transfer for T cell activation. Journal of Cell Biology . 2015;210(5):851–864. doi: 10.1083/jcb.201412074. PubMed DOI PMC

De Zuani M., Paolicelli G., Zelante T., et al. Mast cells respond to Candida albicans infections and modulate macrophages phagocytosis of the fungus. Frontiers in Immunology . 2018;9 doi: 10.3389/fimmu.2018.02829.2829 PubMed DOI PMC

Johnson-Weaver B., Choi H. W., Abraham S. N., Staats H. F. Mast cell activators as novel immune regulators. Current Opinion in Pharmacology . 2018;41:89–95. doi: 10.1016/j.coph.2018.05.004. PubMed DOI PMC

Skokos D., Botros H. G., Demeure C., et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. The Journal of Immunology . 2003;170(6):3037–3045. doi: 10.4049/jimmunol.170.6.3037. PubMed DOI

Kalkusova K., Smite S., Darras E., et al. Mast cells and dendritic cells as cellular immune checkpoints in immunotherapy of solid tumors. International Journal of Molecular Sciences . 2022;23(19) doi: 10.3390/ijms231911080.11080 PubMed DOI PMC

Shelburne C. P., Nakano H., St. John A. L., et al. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host & Microbe . 2009;6(4):331–342. doi: 10.1016/j.chom.2009.09.004. PubMed DOI PMC

Otsuka A., Kubo M., Honda T., et al. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLOS ONE . 2011;6(9) doi: 10.1371/journal.pone.0025538.e25538 PubMed DOI PMC

de Vries V. C., Pino-Lagos K., Nowak E. C., Bennett K. A., Oliva C., Noelle R. J. Mast cells condition dendritic cells to mediate allograft tolerance. Immunity . 2011;35(4):550–561. doi: 10.1016/j.immuni.2011.09.012. PubMed DOI PMC

Patente T. A., Pinho M. P., Oliveira A. A., Evangelista G. C. M., Bergami-Santos P. C., Barbuto J. A. M. Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy. Frontiers in Immunology . 2019;9 doi: 10.3389/fimmu.2018.03176.3176 PubMed DOI PMC

Zhang S., Audiger C., Chopin M., Nutt S. L. Transcriptional regulation of dendritic cell development and function. Frontiers in Immunology . 2023;14 doi: 10.3389/fimmu.2023.1182553.1182553 PubMed DOI PMC

Hubo M., Trinschek B., Kryczanowsky F., Tuettenberg A., Steinbrink K., Jonuleit H. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Frontiers in Immunology . 2013;4 doi: 10.3389/fimmu.2013.00082.82 PubMed DOI PMC

Kim M. K., Kim J. Properties of immature and mature dendritic cells: phenotype, morphology, phagocytosis, and migration. RSC Advances . 2019;9(20):11230–11238. doi: 10.1039/C9RA00818G. PubMed DOI PMC

Valenzuela J., Schmidt C., Mescher M. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. The Journal of Immunology . 2002;169(12):6842–6849. doi: 10.4049/jimmunol.169.12.6842. PubMed DOI

Li D., Wu M. Pattern recognition receptors in health and diseases. Signal Transduction and Targeted Therapy . 2021;6 doi: 10.1038/s41392-021-00687-0.291 PubMed DOI PMC

Hemmi H., Akira S. Mechanisms of Epithelial Defense . Vol. 86. Karger; 2005. TLR signalling and the function of dendritic cells; pp. 120–135. (Chemical Immunology and Allergy). PubMed DOI

Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. Journal of Biological Chemistry . 2014;289(51):35237–35245. doi: 10.1074/jbc.R114.619304. PubMed DOI PMC

Dalod M., Chelbi R., Malissen B., Lawrence T. Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming. The EMBO Journal . 2014;33(10):1104–1116. doi: 10.1002/embj.201488027. PubMed DOI PMC

Rossi M., Young J. W. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. The Journal of Immunology . 2005;175(3):1373–1381. doi: 10.4049/jimmunol.175.3.1373. PubMed DOI

Davidson G. A., Varhol R. J. Kinetics of thapsigargin- Ca2+-ATPase (Sarcoplasmic Reticulum) interaction reveals a two-step binding mechanism and picomolar inhibition. Journal of Biological Chemistry . 1995;270(20):11731–11734. doi: 10.1074/jbc.270.20.11731. PubMed DOI

Kijima Y., Ogunbunmi E., Fleischer S. Drug action of thapsigargin on the Ca2+ pump protein of sarcoplasmic reticulum. The Journal of Biological Chemistry . 1991;266(34):22912–22918. doi: 10.1016/S0021-9258(18)54441-0. PubMed DOI

Lytton J., Westlin M., Hanley M. R. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. The Journal of Biological Chemistry . 1991;266(26):17067–17071. PubMed

Thastrup O., Dawson A. P., Scharff O., et al. Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents and Actions . 1989;27:17–23. doi: 10.1007/BF02222186. PubMed DOI

Holowka D., Calloway N., Cohen R., et al. Roles for ca2+ mobilization and its regulation in mast cell functions. Frontiers in Immunology . 2012;3 doi: 10.3389/fimmu.2012.00104.104 PubMed DOI PMC

Huber M., Hughes M. R., Krystal G. Thapsigargin-induced degranulation of mast cells is dependent on transient activation of phosphatidylinositol-3 kinase. Journal of Immunology . 2000;165(1):124–133. doi: 10.4049/jimmunol.165.1.124. PubMed DOI

Kirshenbaum A. S., Akin C., Wu Y., et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leukemia Research . 2003;27(8):677–682. doi: 10.1016/S0145-2126(02)00343-0. PubMed DOI

Taborska P., Stakheev D., Bartunkova J., Smrz D. Thapsigargin-stimulated LAD2 human mast cell line is a potent cellular adjuvant for the maturation of monocyte-derived dendritic cells for adoptive cellular immunotherapy. International Journal of Molecular Sciences . 2021;22(8) doi: 10.3390/ijms22083978.3978 PubMed DOI PMC

Taborska P., Stakheev D., Svobodova H., Strizova Z., Bartunkova J., Smrz D. Acute conditioning of antigen-expanded CD8+ T cells via the GSK3β-mTORC axis differentially dictates their immediate and distal responses after antigen rechallenge. Cancers . 2020;12(12) doi: 10.3390/cancers12123766.3766 PubMed DOI PMC

Stakheev D., Taborska P., Kalkusova K., Bartunkova J., Smrz D. LL-37 as a powerful molecular tool for boosting the performance of ex vivo-produced human dendritic cells for cancer immunotherapy. Pharmaceutics . 2022;14(12) doi: 10.3390/pharmaceutics14122747.2747 PubMed DOI PMC

Taborska P., Bartunkova J., Smrz D. Simultaneous in vitro generation of human CD34+-derived dendritic cells and mast cells from non-mobilized peripheral blood mononuclear cells. Journal of Immunological Methods . 2018;458:63–73. doi: 10.1016/j.jim.2018.04.005. PubMed DOI

Smrz D., Cruse G., Beaven M. A., Kirshenbaum A., Metcalfe D. D., Gilfillan A. M. Rictor negatively regulates high-affinity receptors for IgE-induced mast cell degranulation. Journal of Immunology . 2014;193(12):5924–5932. doi: 10.4049/jimmunol.1303495. PubMed DOI PMC

Cruse G., Beaven M. A., Ashmole I., Bradding P., Gilfillan A. M., Metcalfe D. D. A truncated splice-variant of the FcεRIβ receptor subunit is critical for microtubule formation and degranulation in mast cells. Immunity . 2013;38(5):906–917. doi: 10.1016/j.immuni.2013.04.007. PubMed DOI PMC

Taborska P., Lastovicka J., Stakheev D., Strizova Z., Bartunkova J., Smrz D. SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors. Immunity, Inflammation and Disease . 2021;9(4):1452–1467. doi: 10.1002/iid3.496. PubMed DOI PMC

Pufnock J. S., Cigal M., Rolczynski L. S., et al. Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28. Blood . 2011;117(24):6542–6551. doi: 10.1182/blood-2010-11-317966. PubMed DOI PMC

Halliday N., Williams C., Kennedy A., et al. CD86 is a selective CD28 ligand supporting FoxP3+ regulatory T cell homeostasis in the presence of high levels of CTLA-4. Frontiers in Immunology . 2020;11 doi: 10.3389/fimmu.2020.600000.600000 PubMed DOI PMC

Baravalle G., Park H., McSweeney M., et al. Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells. Journal of Immunology . 2011;187(6):2966–2973. doi: 10.4049/jimmunol.1101643. PubMed DOI PMC

Fucikova J., Palova-Jelinkova L., Bartunkova J., Spisek R. Induction of tolerance and immunity by dendritic cells: mechanisms and clinical applications. Frontiers in Immunology . 2019;10 doi: 10.3389/fimmu.2019.02393.2393 PubMed DOI PMC

Zhang B., Alysandratos K.-D., Angelidou A., et al. Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis. The Journal of Allergy and Clinical Immunology . 2011;127(6):1522–1522.e8. doi: 10.1016/j.jaci.2011.02.005. PubMed DOI PMC

Oh S. A., Wu D.-C., Cheung J., et al. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nature Cancer . 2020;1:681–691. doi: 10.1038/s43018-020-0075-x. PubMed DOI

Wolf Y., Anderson A. C., Kuchroo V. K. TIM3 comes of age as an inhibitory receptor. Nature Reviews Immunology . 2020;20:173–185. doi: 10.1038/s41577-019-0224-6. PubMed DOI PMC

Tomiyama M., Takahara M., Egawa K., Nieda M. Mature dendritic cells are superior to immature dendritic cells in expanding antigen-specific naive and memory CD8+ T cells. Anticancer Research . 2004;24(5C):3327–3333. PubMed

Benvenuti F., Lagaudriere-Gesbert C., Grandjean I., et al. Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes. The Journal of Immunology . 2004;172(1):292–301. doi: 10.4049/jimmunol.172.1.292. PubMed DOI

Calzascia T., Pellegrini M., Hall H., et al. TNF-α is critical for antitumor but not antiviral T cell immunity in mice. Journal of Clinical Investigation . 2007;117(12):3833–3845. doi: 10.1172/JCI32567. PubMed DOI PMC

Tourkova I. L., Yurkovetsky Z. R., Shurin M. R., Shurin G. V. Mechanisms of dendritic cell-induced T cell proliferation in the primary MLR assay. Immunology Letters . 2001;78(2):75–82. doi: 10.1016/S0165-2478(01)00235-8. PubMed DOI

Lašťovička J., Rataj M., Bartůňková J. Assessment of lymphocyte proliferation for diagnostic purpose: Comparison of CFSE staining, Ki-67 expression and 3H-thymidine incorporation. Human Immunology . 2016;77(12):1215–1222. doi: 10.1016/j.humimm.2016.08.012. PubMed DOI

Moon T. C., Befus A. D., Kulka M. Mast cell mediators: their differential release and the secretory pathways involved. Frontiers in Immunology . 2014;5 doi: 10.3389/fimmu.2014.00569.569 PubMed DOI PMC

Klein O., Sagi-Eisenberg R. Anaphylactic degranulation of mast cells: focus on compound exocytosis. Journal of Immunology Research . 2019 PubMed PMC

Blank U. Mast Cell Biology . Vol. 716. Boston, MA: Springer; 2011. The mechanisms of exocytosis in mast cells; pp. 107–122. (Advances in Experimental Medicine and Biology). PubMed DOI

Jin P., Han T. H., Ren J., et al. Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies. Journal of Translational Medicine . 2010;8 doi: 10.1186/1479-5876-8-4.4 PubMed DOI PMC

Giorello M. B., Matas A., Marenco P., et al. CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients. Breast Cancer . 2021;28:1328–1339. doi: 10.1007/s12282-021-01270-9. PubMed DOI

Sosa Cuevas E., Ouaguia L., Mouret S., et al. BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients. Clinical & Translational Immunology . 2020;9(11) doi: 10.1002/cti2.1190.e1190 PubMed DOI PMC

Gulubova M. V., Ananiev J. R., Vlaykova T. I., Yovchev Y., Tsoneva V., Manolova I. M. Role of dendritic cells in progression and clinical outcome of colon cancer. International Journal of Colorectal Disease . 2012;27(2):159–169. doi: 10.1007/s00384-011-1334-1. PubMed DOI

Brown R. D., Pope B., Murray A., et al. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10. Blood . 2001;98(10):2992–2998. doi: 10.1182/blood.V98.10.2992. PubMed DOI

Vicari A. P., Chiodoni C., Vaure C., et al. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti–interleukin 10 receptor antibody. Journal of Experimental Medicine . 2002;196(4):541–549. doi: 10.1084/jem.20020732. PubMed DOI PMC

Perrot I., Blanchard D., Freymond N., et al. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. The Journal of Immunology . 2007;178(5):2763–2769. doi: 10.4049/jimmunol.178.5.2763. PubMed DOI

Bergeron A., El Hage F., Kambouchner M., Lecossier D., Tazi A. Characterisation of dendritic cell subsets in lung cancer micro-environments. European Respiratory Journal . 2006;28(6):1170–1177. doi: 10.1183/09031936.06.00114205. PubMed DOI

Pei Y., Zhu Y., Wang X., Xu L. The expression and clinical value of tumor infiltrating dendritic cells in tumor tissues of patients with esophageal cancer. Journal of Gastrointestinal Oncology . 2021;15:1996–2003. doi: 10.21037/jgo-21-578. PubMed DOI PMC

Janco J. M. T., Lamichhane P., Karyampudi L., Knutson K. L. Tumor-infiltrating dendritic cells in cancer pathogenesis. The Journal of Immunology . 2015;194(7):2985–2991. doi: 10.4049/jimmunol.1403134. PubMed DOI PMC

Cools N., Van Tendeloo V. F. I., Smits E. L. J. M., et al. Immunosuppression induced by immature dendritic cells is mediated by TGF-β/IL-10 double-positive CD4+ regulatory T cells. Journal of Cellular and Molecular Medicine . 2008;12(2):690–700. doi: 10.1111/j.1582-4934.2007.00084.x. PubMed DOI PMC

Dudek A. M., Martin S., Garg A. D., Agostinis P. Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Frontiers in Immunology . 2013;4 doi: 10.3389/fimmu.2013.00438.438 PubMed DOI PMC

Li J., Zhou J., Huang H., Jiang J., Zhang T., Ni C. Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): a novel population in the tumour microenvironment and immunotherapy target. Clinical and Translational Medicine . 2023;13(2) doi: 10.1002/ctm2.1199.e1199 PubMed DOI PMC

Bluth M. J., Zaba L. C., Moussai D., et al. Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation. Journal of Investigative Dermatology . 2009;129(10):2451–2462. doi: 10.1038/jid.2009.96. PubMed DOI PMC

Hodge J. W., Rad A. N., Grosenbach D. W., et al. Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules. JNCI Journal of the National Cancer Institute . 2000;92(15):1228–1239. doi: 10.1093/jnci/92.15.1228. PubMed DOI

Blanco P., Palucka A. K., Pascual V., Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine & Growth Factor Reviews . 2008;19(1):41–52. doi: 10.1016/j.cytogfr.2007.10.004. PubMed DOI PMC

deLuca L. S., Gommerman J. L. Fine-tuning of dendritic cell biology by the TNF superfamily. Nature Reviews Immunology . 2012;12(5):339–351. doi: 10.1038/nri3193. PubMed DOI

Hamza T., Barnett J. B., Li B. Interleukin 12 a key immunoregulatory cytokine in infection applications. International Journal of Molecular Sciences . 2010;11(3):789–806. doi: 10.3390/ijms11030789. PubMed DOI PMC

Ludewig B., Graf D., Gelderblom H. R., Becker Y., Kroczek R. A., Pauli G. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. European Journal of Immunology . 1995;25(7):1943–1950. doi: 10.1002/eji.1830250722. PubMed DOI

van Lieshout A. W. T. Inhibition of TNF during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF blockade in rheumatoid arthritis. Annals of The Rheumatic Diseases . 2005;64(3):408–414. doi: 10.1136/ard.2004.023259. PubMed DOI PMC

Miwa S., Nishida H., Tanzawa Y., et al. TNF-α and tumor lysate promote the maturation of dendritic cells for immunotherapy for advanced malignant bone and soft tissue tumors. PLOS ONE . 2012;7(12) doi: 10.1371/journal.pone.0052926.e52926 PubMed DOI PMC

Zhang W., Chen Z., Li F., et al. Tumour necrosis factor-α (TNF-α) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-α. Immunology . 2003;108(2):177–188. doi: 10.1046/j.1365-2567.2003.01489.x. PubMed DOI PMC

Eastman A. J., Xu J., Bermik J., et al. Epigenetic stabilization of DC and DC precursor classical activation by TNFα contributes to protective T cell polarization. Science Advances . 2019;5(12) doi: 10.1126/sciadv.aaw9051.eaaw9051 PubMed DOI PMC

Athie-Morales V., Smits H. H., Cantrell D. A., Hilkens C. M. Sustained IL-12 signaling is required for Th1 development. The Journal of Immunology . 2004;172(1):61–69. doi: 10.4049/jimmunol.172.1.61. PubMed DOI

Bhardwaj N., Seder R. A., Reddy A., Feldman M. V. IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. Journal of Clinical Investigation . 1996;98(3):715–722. doi: 10.1172/JCI118843. PubMed DOI PMC

Heufler C., Koch F., Stanzl U., et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells. European Journal of Immunology . 1996;26(3):659–668. doi: 10.1002/eji.1830260323. PubMed DOI

Kieper W. C., Prlic M., Schmidt C. S., Mescher M. F., Jameson S. C. IL-12 enhances CD8 T cell homeostatic expansion. The Journal of Immunology . 2001;166(9):5515–5521. doi: 10.4049/jimmunol.166.9.5515. PubMed DOI

Henry C. J., Ornelles D. A., Mitchell L. M., Brzoza-Lewis K. L., Hiltbold E. M. IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. The Journal of Immunology . 2008;181(12):8576–8584. doi: 10.4049/jimmunol.181.12.8576. PubMed DOI PMC

Curtsinger J. M., Lins D. C., Mescher M. F. Signal 3 determines tolerance versus full activation of naive CD8 T cells. The Journal of Experimental Medicine . 2003;197(9):1141–1151. doi: 10.1084/jem.20021910. PubMed DOI PMC

Banerjee H., Kane L. P. Immune regulation by Tim-3. F1000Research . 2018;7 doi: 10.12688/f1000research.13446.1.316 PubMed DOI PMC

de Mingo Pulido Á., Hänggi K., Celias D. P., et al. The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake. Immunity . 2021;54(6):1154–1167.e7. doi: 10.1016/j.immuni.2021.04.019. PubMed DOI PMC

Wang H., Hu S., Chen X., et al. cGAS is essential for the antitumor effect of immune checkpoint blockade. Proceedings of the National Academy of Sciences . 2017;114(7):1637–1642. doi: 10.1073/pnas.1621363114. PubMed DOI PMC

Vatner R. E., Janssen E. M. STING, DCs and the link between innate and adaptive tumor immunity. Molecular Immunology . 2019;110:13–23. doi: 10.1016/j.molimm.2017.12.001. PubMed DOI PMC

Pagliano O., Morrison R. M., Chauvin J.-M., et al. Tim-3 mediates T cell trogocytosis to limit antitumor immunity. Journal of Clinical Investigation . 2022;132(9) doi: 10.1172/JCI152864.e152864 PubMed DOI PMC

Gardner A., de Mingo Pulido Á., Hänggi K., et al. TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization. Journal for ImmunoTherapy of Cancer . 2022;10(1) doi: 10.1136/jitc-2021-003571.e003571 PubMed DOI PMC

de Mingo Pulido Á., Gardner A., Hiebler S., et al. TIM-3 regulates CD103+ dendritic cell function and response to chemotherapy in breast cancer. Cancer Cell . 2018;33(1):60–74.e6. doi: 10.1016/j.ccell.2017.11.019. PubMed DOI PMC

Dixon K. O., Tabaka M., Schramm M. A., et al. TIM-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature . 2021;595(7865):101–106. doi: 10.1038/s41586-021-03626-9. PubMed DOI PMC

Raskov H., Orhan A., Christensen J. P., Gögenur I. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. British Journal of Cancer . 2021;124:359–367. doi: 10.1038/s41416-020-01048-4. PubMed DOI PMC

Alfei F., Ho P.-C., Lo W.-L. DCision-making in tumors governs T cell anti-tumor immunity. Oncogene . 2021;40(34):5253–5261. doi: 10.1038/s41388-021-01946-8. PubMed DOI PMC

Gupta Y. H., Khanom A., Acton S. E. Control of dendritic cell function within the tumour microenvironment. Frontiers in Immunology . 2022;13 doi: 10.3389/fimmu.2022.733800.733800 PubMed DOI PMC

Ribatti D. Mast cells and resistance to immunotherapy in cancer. Archivum Immunologiae et Therapiae Experimentalis . 2023;71 doi: 10.1007/s00005-023-00676-x.11 PubMed DOI PMC

Nishimura T., Nakui M., Sato M., et al. The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemotherapy and Pharmacology . 2000;46:S52–S61. doi: 10.1007/PL00014051. PubMed DOI

Backer R. A., Probst H. C., Clausen B. E. Classical DC2 subsets and monocyte-derived DC: delineating the developmental and functional relationship. European Journal of Immunology . 2023;53(3) doi: 10.1002/eji.202149548.e2149548 PubMed DOI

Azeem W., Bakke R. M., Appel S., Øyan A. M., Kalland K.-H. Dual pro- and anti-inflammatory features of monocyte-derived dendritic cells. Frontiers in Immunology . 2020;11 doi: 10.3389/fimmu.2020.00438.438 PubMed DOI PMC

Frei R., Ferstl R., Konieczna P., et al. Histamine receptor 2 modifies dendritic cell responses to microbial ligands. Journal of Allergy and Clinical Immunology . 2013;132(1):194–204.e12. doi: 10.1016/j.jaci.2013.01.013. PubMed DOI